Nyumbani › Saratani (aina zote) › Oklahoma
Majaribio ya kliniki ya Saratani (aina zote) katika jimbo la Oklahoma
Masomo 15 ya Saratani (aina zote) yanatafuta washiriki katika vituo vya jimbo la Oklahoma.
Miji katika jimbo la Oklahoma
Maandishi rasmi ya utafiti (Kiingereza)
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- OU Health - Stephenson Cancer Center /ID# 277656, Oklahoma City
InaajiriHatua 2
Umri 18 na zaidi · Wanawake · Imesasishwa 1 Okt 2026 · NCT07024784Registry Study for Radiation Therapy Outcomes
- Oklahoma Proton Center, Oklahoma City
InaajiriUtafiti wa uchunguzi
Umri wote · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT01255748Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- University of Oklahoma, Oklahoma City
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT06128551Prospective Study to Assess a Diagnostic Aid for Cancer
- Hightower Clinical, Oklahoma City
InaajiriUtafiti wa uchunguzi
Umri 45 na zaidi · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT07046260Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- University of Oklahoma Peggy and Charles Stephenson Cancer Center, Oklahoma City
InaajiriHatua 2/3
Umri wote · Jinsia zote · Imesasishwa 18 Sep 2026 · NCT03435796A Phase 1/1b Study of IAM1363 in HER2 Cancers
- OU Health Stephenson Cancer Center, Oklahoma City
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 9 Sep 2026 · NCT06253871Project: Every Child for Younger Patients With Cancer
- University of Oklahoma Health Sciences Center, Oklahoma City
- Saint Francis Children's Hospital, Tulsa
InaajiriUtafiti wa uchunguzi
Hadi umri 25 · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT02402244Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 7 Ago 2026 · NCT06580314Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Mercy Hospital - OKC, Oklahoma City
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 29 Jun 2026 · NCT07327489GEMINI-NSCLC: NSCLC Biomarker Study
- Hightower Clinical, Oklahoma City
- Mercy Clinic Oncology and Hematology - Coletta, Oklahoma City
- Oklahoma Cancer Specialists and Research Institute, Tulsa
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 5 Feb 2026 · NCT05236114Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
- Oklahoma University Stephenson Cancer Center, Oklahoma City
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 13 Nov 2025 · NCT05997017SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Tulsa
InaajiriUtafiti wa uchunguzi
Umri wote · Jinsia zote · Imesasishwa 28 Okt 2025 · NCT03452774A Study of NX-1607 in Adults With Advanced Malignancies
- University of Oklahoma, Oklahoma City
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 9 Sep 2025 · NCT05107674Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
- Mercy Clinic Oncology and Hematology - Coletta, Oklahoma City
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 6 Mei 2025 · NCT05234177Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- OUHSC Stephenson Cancer Center, Oklahoma City
- Mercy Health Center - Oncology Hematology, Oklahoma City
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 27 Nov 2024 · NCT03860883Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.